Glasdegib Completed Phase 1 Trials for Tumors, Solid Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT01286467A Study Of PF-04449913 Administered Alone In Select Solid Tumors